A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant gain of 407.73% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 91.06%. Over the past 30 days, the price of RNA has fallen by 4.01%. And in the last five days, it has surged by 2.96%.
The market performance of Avidity Biosciences Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $48.80 on 07/29/24, with the lowest value for the same timeframe being $4.82, recorded on 10/31/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of RNA Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Avidity Biosciences Inc’s current trading price is -5.84% away from its 52-week high, while its distance from the 52-week low is 852.33%. The stock’s price range for this period has been between $4.82 and $48.80. The Healthcare sector company’s shares saw a trading volume of about 2.36 million for the day, which was higher than the average daily volume of 1.51 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Avidity Biosciences Inc (RNA) has experienced a quarterly rise of 15.13% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.38B and boasts a workforce of 253 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 38.61, with a change in price of +20.37. Similarly, Avidity Biosciences Inc recorded 1,567,783 in trading volume during the last 100 days, posting a change of +79.63%.
RNA’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for RNA stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
RNA Stock Stochastic Average
As of today, the raw stochastic average of Avidity Biosciences Inc over the last 50 days is at 75.76%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 91.79%. Further, the company’s Stochastic %K and %D values for the last 20 days were 74.12% and 73.37%, respectively.
